NSEPendency of Litigation(s)/dispute(s) or the outcome impacting the Company26 Jun 2026 · 26 Jun 2026, 07:53 pm

Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

Gujarat Themis Biosyn Limited · GUJTHEM

✦ AI SummaryLitigation

Gujarat Themis Biosyn Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company, specifically an arbitration proceeding initiated against Optimus Drugs Private Limited for breach of supply agreement terms.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Gujarat Themis Biosyn Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

Attachments (1)

📄

GUJARATTHEMIS_26062026195259_Reg30IntimationBSENSEGTBL26062026.pdf

pdf

Download →
View document text
GUJARAT THEMIS BIOSYN LIMITED CIN: L24230GJ1981PLC004878 REGD. OFFICE &FACTORY: 69/C GIDC INDUSTRIAL ESTATE, VAPI – 396 195, DIST. VALSAD, GUJARAT, INDIA TEL: 0260-2430027 / 2400639 E-mail:hrm@gtbl.in.net GTBL/BSE/NSE/2026-27/32 26th June, 2026 Corporate Relationship Department Listing Department BSE Limited National Stock Exchange of India Limited Floor 25, Phiroze Jeejeebhoy Towers Exchange Plaza, Dalal Street, Mumbai- 400001 Bandra Kurla Complex, Scrip Code – 506879 Bandra (East), Mumbai- 400051 Symbol: GUJTHEM Sub.: Disclosure under Reg 30 of the SEBI LODR Regulations 2015 - litigation or disputes Dear Sirs / Madam, This is to inform you about material litigation or disputes in relation to initiation of an arbitration proceeding by the Company, against the party as per the details mentioned below. Sr. Particular Details 1 Brief Details of Litigation Arbitration proceeding Name of the Company Gujarat Themis Biosyn Limited (GTBL or Claimant) Name(s) of the opposing Optimus Drugs Private Limited (Optimus Drugs or Respondent) party Court/ Tribunal / Agency Before the Learned Sole Arbitrator. where Litigation is filed Brief details of dispute / Optimus Drug terminated supply agreement contrary to the litigation agreed terms. The Company being aggrieved in this respect, has initiated arbitration proceeding against the Optimus Drugs, claiming inter alia; (a) Rs. 75,00,00,000 towards Break Fees because Optimus Drugs breached the mandatory "Take-or-Pay" minimum purchase obligations outlined in the agreement; (b) Rs. 23,80,849/- towards the interest on Delayed Payments, and further interest till actual payment; (c) Rs. 15,00,00,000/- towards the damages and financial losses; and (d) costs, other relief as the Hon’ble Tribunal may deem fit. 2 Expected financial Since the Company has initiated arbitration proceeding claiming implications, if any, due to recovery and damage, we do not expect any financial compensation, penalty, etc. implication due to penalty etc. 3 Quantum of claims if any As mentioned above. The above is pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 / applicable statutory provisions and for your information. Thanking You Yours faithfully For Gujarat Themis Biosyn Limited Vineet Gawankar Company Secretary & Compliance Officer MUMBAI OFFICE: Themis House, 11/12 Udyog Nagar, S.V Road, Goregaon (West), Mumbai – 400 104 Tel: 91-22-67607080 / 28757836 Fax: 28746621 / 67607019; E-mail: gtblmumbai@gtbl.in Website Address: www.gtbl.in